Industry Growth Insights published a new data on “Precision Medicine Diagnostics Market”. The research report is titled “Precision Medicine Diagnostics Market research by Types (Bioinformatics, Gene Sequencing, Drug Discovery, Precision Molecular Diagnostics, Big Data Analytics), By Applications (Oncology, CNS, Hematology, Respiratory, Immunology, Others), By Players/Companies Intomics, Ferrer Incode, Nanostring Technologies, Tepnel Pharma Services, Pfizer, Novartis, Teva Pharmaceuticals, Merck & Co., Qiagen, Quest Diagnostics”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Precision Medicine Diagnostics Market Research Report
By Type
Bioinformatics, Gene Sequencing, Drug Discovery, Precision Molecular Diagnostics, Big Data Analytics
By Application
Oncology, CNS, Hematology, Respiratory, Immunology, Others
By Companies
Intomics, Ferrer Incode, Nanostring Technologies, Tepnel Pharma Services, Pfizer, Novartis, Teva Pharmaceuticals, Merck & Co., Qiagen, Quest Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
179
Number of Tables & Figures
126
Customization Available
Yes, the report can be customized as per your need.
Global Precision Medicine Diagnostics Market Report Segments:
The global Precision Medicine Diagnostics market is segmented on the basis of:
Types
Bioinformatics, Gene Sequencing, Drug Discovery, Precision Molecular Diagnostics, Big Data Analytics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, CNS, Hematology, Respiratory, Immunology, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Intomics
- Ferrer Incode
- Nanostring Technologies
- Tepnel Pharma Services
- Pfizer
- Novartis
- Teva Pharmaceuticals
- Merck & Co.
- Qiagen
- Quest Diagnostics
Highlights of The Precision Medicine Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Bioinformatics
- Gene Sequencing
- Drug Discovery
- Precision Molecular Diagnostics
- Big Data Analytics
- By Application:
- Oncology
- CNS
- Hematology
- Respiratory
- Immunology
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Precision Medicine Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Precision Medicine Diagnostics is a company that provides diagnostic services for patients with rare diseases. The company offers tests that are used to diagnose and treat rare diseases. Precision Medicine Diagnostics also provides information about the disease to doctors and patients.
Some of the major players in the precision medicine diagnostics market are Intomics, Ferrer Incode, Nanostring Technologies, Tepnel Pharma Services, Pfizer, Novartis, Teva Pharmaceuticals, Merck & Co., Qiagen, Quest Diagnostics.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Precision Medicine Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Precision Medicine Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Precision Medicine Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Precision Medicine Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Precision Medicine Diagnostics Market Size & Forecast, 2018-2028
4.5.1 Precision Medicine Diagnostics Market Size and Y-o-Y Growth
4.5.2 Precision Medicine Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Precision Medicine Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Precision Medicine Diagnostics Market Size Forecast by Type
5.2.1 Bioinformatics
5.2.2 Gene Sequencing
5.2.3 Drug Discovery
5.2.4 Precision Molecular Diagnostics
5.2.5 Big Data Analytics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Precision Medicine Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Precision Medicine Diagnostics Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 CNS
6.2.3 Hematology
6.2.4 Respiratory
6.2.5 Immunology
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Precision Medicine Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Precision Medicine Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Precision Medicine Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America Precision Medicine Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Precision Medicine Diagnostics Market Size Forecast by Type
9.6.1 Bioinformatics
9.6.2 Gene Sequencing
9.6.3 Drug Discovery
9.6.4 Precision Molecular Diagnostics
9.6.5 Big Data Analytics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Precision Medicine Diagnostics Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 CNS
9.10.3 Hematology
9.10.4 Respiratory
9.10.5 Immunology
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Precision Medicine Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe Precision Medicine Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Precision Medicine Diagnostics Market Size Forecast by Type
10.6.1 Bioinformatics
10.6.2 Gene Sequencing
10.6.3 Drug Discovery
10.6.4 Precision Molecular Diagnostics
10.6.5 Big Data Analytics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Precision Medicine Diagnostics Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 CNS
10.10.3 Hematology
10.10.4 Respiratory
10.10.5 Immunology
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Precision Medicine Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Precision Medicine Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Precision Medicine Diagnostics Market Size Forecast by Type
11.6.1 Bioinformatics
11.6.2 Gene Sequencing
11.6.3 Drug Discovery
11.6.4 Precision Molecular Diagnostics
11.6.5 Big Data Analytics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Precision Medicine Diagnostics Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 CNS
11.10.3 Hematology
11.10.4 Respiratory
11.10.5 Immunology
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Precision Medicine Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America Precision Medicine Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Precision Medicine Diagnostics Market Size Forecast by Type
12.6.1 Bioinformatics
12.6.2 Gene Sequencing
12.6.3 Drug Discovery
12.6.4 Precision Molecular Diagnostics
12.6.5 Big Data Analytics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Precision Medicine Diagnostics Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 CNS
12.10.3 Hematology
12.10.4 Respiratory
12.10.5 Immunology
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Precision Medicine Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Precision Medicine Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Precision Medicine Diagnostics Market Size Forecast by Type
13.6.1 Bioinformatics
13.6.2 Gene Sequencing
13.6.3 Drug Discovery
13.6.4 Precision Molecular Diagnostics
13.6.5 Big Data Analytics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Precision Medicine Diagnostics Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 CNS
13.10.3 Hematology
13.10.4 Respiratory
13.10.5 Immunology
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Precision Medicine Diagnostics Market: Competitive Dashboard
14.2 Global Precision Medicine Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Intomics
14.3.2 Ferrer Incode
14.3.3 Nanostring Technologies
14.3.4 Tepnel Pharma Services
14.3.5 Pfizer
14.3.6 Novartis
14.3.7 Teva Pharmaceuticals
14.3.8 Merck & Co.
14.3.9 Qiagen
14.3.10 Quest Diagnostics
